Announcing our Series B

Today Navina is celebrating our $22 million Series B funding round, doubling our total investment to date to $44 million.

This is a huge milestone for us in a year that is already filled with huge milestones: In 2022 we were honored to see thousands of new clinicians using our platform, impacted millions of patient lives, drove a 10x increase in revenue, and more than doubled our team (and it’s still growing).  

We started Navina with the goal of using data to transform every provider-patient interaction, changing it from reactive to proactive. We came together with the clear understanding that no human can digest the amount of data required to keep us all healthy. Today, we’re well on our way to achieving our goal by using medically-informed AI to make sense of the exponentially increasing amounts of data that clinicians are overwhelmed by.

Powering Navina is a strong, hardworking team of AI, medical, development, product, and business superstars. Together they have a nuanced understanding of primary care workflows that enables us to lift data burdens off clinicians, allowing them to take better care of their patients. The Navina team is a joy to work with, and an integral part of our journey. We’re proud and thankful for the team’s agility; transparent, direct conversation; and of course friendship—and look forward to more creativity and productivity in this next stage of growth.  

We’re constantly evolving our platform thanks to the feedback we get from our users, and we want to say a huge thank you to the thousands of clinicians, medical assistants, and coders who turn to us every day to make sure they don’t miss any critical data.

So where do we go from here? We will further invest in our AI technology and clinical algorithms, and expand our integration of more emerging data sources to deliver clinicians a single source of truth—no matter how complex the information.

We are grateful for the continued support of Vertex and Schusterman; of Grove Ventures - who has been with us since the beginning; and of ALIVE who have now joined our family of investors. We look forward to realizing together our vision of a new era of AI-powered care.